Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?

McBride KA, Ballinger ML, Schlub TE, Young MA, Tattersall MHN, Kirk J, Eeles R, Killick E, Walker LG, Shanley S, Thomas DM, Mitchell G.

Fam Cancer. 2017 Jul;16(3):423-432. doi: 10.1007/s10689-016-9964-7.

PMID:
28124295
2.

Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.

Fielding S, Rothnie K, Gray NM, Little J, Cruickshank ME, Neal K, Walker LG, Whynes D, Cotton SC, Sharp L; In association with the TOMBOLA group.

Psychooncology. 2017 Apr;26(4):476-483. doi: 10.1002/pon.4163. Epub 2016 Jun 14.

3.

Long-Term Worries after Colposcopy: Which Women Are at Increased Risk?

Sharp L, Cotton SC, Cruickshank ME, Gray NM, Neal K, Rothnie K, Thornton AJ, Walker LG, Little J; TOMBOLA Group.

Womens Health Issues. 2015 Sep-Oct;25(5):517-27. doi: 10.1016/j.whi.2015.04.002. Epub 2015 Jun 4.

PMID:
26051021
4.
5.

A normal colposcopy examination fails to provide psychological reassurance for women who have had low-grade abnormal cervical cytology.

Cotton SC, Sharp L, Little J, Gray NM, Walker LG, Whynes DK, Cruickshank ME; TOMBOLA Group.

Cytopathology. 2015 Jun;26(3):178-87. doi: 10.1111/cyt.12173. Epub 2014 Aug 6.

PMID:
25099940
6.

Management of women with low grade cytology: how reassuring is a normal colposcopy examination?

Cruickshank ME, Cotton SC, Sharp L, Smart L, Walker LG, Little J; TOMBOLA Group.

BJOG. 2015 Feb;122(3):380-6. doi: 10.1111/1471-0528.12932. Epub 2014 Jun 20.

7.

Measuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM).

Rothnie K, Cotton SC, Fielding S, Gray NM, Little J, Cruickshank ME, Walker LG, Avis M, Sharp L.

Health Qual Life Outcomes. 2014;12:154.

8.

Baseline quality of life factors predict long term survival after elective resection for colorectal cancer.

Sharma A, Walker LG, Monson JR.

Int J Surg Oncol. 2013;2013:269510. doi: 10.1155/2013/269510. Epub 2013 Nov 27.

9.

The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance.

Sharp L, Cotton S, Cruickshank M, Gray NM, Harrild K, Smart L, Walker LG, Little J; TOMBOLA Group.

J Low Genit Tract Dis. 2014 Apr;18(2):142-50. doi: 10.1097/LGT.0b013e31829c97d8.

PMID:
24270192
10.

Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer.

Walker LG, Eremin JM, Aloysius MM, Vassanasiri W, Walker MB, El-Sheemy M, Cowley G, Beer J, Samphao S, Wiseman J, Jibril JA, Valerio D, Clarke DJ, Kamal M, Thorpe GW, Baria K, Eremin O.

BMC Cancer. 2011 May 18;11:179. doi: 10.1186/1471-2407-11-179.

11.

Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study.

Hutton J, Walker LG, Gilbert FJ, Evans DG, Eeles R, Kwan-Lim GE, Thompson D, Pointon LJ, Sharp DM, Leach MO; UK Study Group for MRI Screening in Women at High Risk Study.

Br J Cancer. 2011 Feb 15;104(4):578-86. doi: 10.1038/bjc.2011.1.

12.

Differences in cytokine levels due to gender in colorectal cancer patients.

Sharma A, Greenman J, Walker LG, Monson JR.

Cytokine. 2010 Apr;50(1):91-3. doi: 10.1016/j.cyto.2010.01.002. Epub 2010 Jan 29.

PMID:
20116278
13.

Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage.

Green VL, Alexandropoulou A, Walker MB, Walker AA, Sharp DM, Walker LG, Greenman J.

Exp Ther Med. 2010 Jan;1(1):97-108. Epub 2010 Jan 1.

14.

Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE).

Turnbull LW, Brown SR, Olivier C, Harvey I, Brown J, Drew P, Hanby A, Manca A, Napp V, Sculpher M, Walker LG, Walker S; COMICE Trial Group.

Health Technol Assess. 2010 Jan;14(1):1-182. doi: 10.3310/hta14010.

15.

Demographic characteristics of patients using a fully integrated psychosocial support service for cancer patients.

Sharp DM, Walker MB, Bateman JS, Braid F, Hebblewhite C, Hope T, Lines M, Walker AA, Walker LG.

BMC Res Notes. 2009 Dec 15;2:253. doi: 10.1186/1756-0500-2-253.

16.

A randomised, controlled trial of the psychological effects of reflexology in early breast cancer.

Sharp DM, Walker MB, Chaturvedi A, Upadhyay S, Hamid A, Walker AA, Bateman JS, Braid F, Ellwood K, Hebblewhite C, Hope T, Lines M, Walker LG.

Eur J Cancer. 2010 Jan;46(2):312-22. doi: 10.1016/j.ejca.2009.10.006. Epub 2009 Nov 10.

PMID:
19906525
17.

Psycho-science: where do we go from here?

Walker LG.

Eur J Cancer. 2009 Sep;45 Suppl 1:455-6. doi: 10.1016/S0959-8049(09)70087-5. No abstract available.

PMID:
19775669
18.

Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast cancer undergoing multimodality therapy: a randomised controlled trial.

Eremin O, Walker MB, Simpson E, Heys SD, Ah-See AK, Hutcheon AW, Ogston KN, Sarkar TK, Segar A, Walker LG.

Breast. 2009 Feb;18(1):17-25. doi: 10.1016/j.breast.2008.09.002. Epub 2008 Nov 12.

PMID:
19008099
19.

Psychosocial factors and quality of life in colorectal cancer.

Sharma A, Walker AA, Sharp DM, Monson JR, Walker LG.

Surgeon. 2007 Dec;5(6):344-54. Review.

PMID:
18080609
20.

Colorectal MDTs: the team's perspective.

Sharma A, Sharp DM, Walker LG, Monson JR.

Colorectal Dis. 2008 Jan;10(1):63-8.

PMID:
18078461

Supplemental Content

Loading ...
Support Center